Boardroom Alpha
Meeting calendar
LTRX · Annual meeting · Tuesday, November 3, 2026

Lantronix Inc

5 nominees · 4 ballot items.

Stockholders will vote on the election of five directors, ratification of Baker Tilly US, LLP as independent registered public accountants, advisory approval of named executive officer compensation, and approval of an amendment to the 2020 Performance Incentive Plan increasing its share reserve by 1,800,000 shares.

Market cap
$241M
1Y TSR
+22.6%
Board grade
A
Record date
Sep 8, 2026
Filing
DEF 14A
Meeting concluded · Nov 3, 2026

Follow how the vote landed and what changed on Lantronix Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect Saleel Awsare, Sailesh Chittipeddi, Narbeh Derhacobian, Jason Lamb and Kevin Palatnik to one-year terms ending at the 2027 Annual Meeting or until their successors are elected and qualified.

  2. 2

    Ratification of Appointment of Independent Registered Public Accountants

    ManagementBoard: FOR

    Ratify the Audit Committee’s appointment of Baker Tilly US, LLP as Lantronix’s independent registered public accounting firm for the fiscal year ending June 30, 2027.

  3. 3

    Advisory Approval of Compensation for Named Executive Officers

    ManagementBoard: FOR

    Approve, on a non-binding advisory basis, the compensation paid and payable to the named executive officers as disclosed in the proxy statement, including the compensation tables and narrative discussion.

    More detail

    Proposal 3 asks stockholders to approve, on a non-binding advisory basis, the compensation paid and payable to Lantronix’s named executive officers. The resolution covers the compensation tables and narrative disclosures in the Executive Compensation section of the proxy statement. Management says the program is designed to align executive financial interests with stockholders and motivate achievement of short- and long-term corporate goals. The program combines base salary, annual cash incentives, performance-based stock units, and time-based restricted stock units. Fiscal 2026 annual incentives were tied to revenue, non-GAAP EPS, and strategic Key Operating Drivers, with payouts capped at 200% of target and ultimately limited to 80% of target by the funded bonus pool. Long-term awards include financial performance measures and relative total shareholder return measured against the Russell Microcap Index. The company emphasizes governance features including multi-year vesting, a clawback policy, anti-hedging and anti-pledging restrictions, no tax gross-ups, and double-trigger change-in-control benefits. Approximately 93.9% of votes cast supported the prior year’s say-on-pay proposal, and the Board and Compensation Committee considered that support when setting fiscal 2026 compensation. Although the vote is advisory and does not bind the Company or create additional fiduciary duties, the Board and Compensation Committee state that they will consider the outcome when evaluating future compensation policies. The Board unanimously recommends a vote FOR approval.

  4. 4

    Approval of Amendment to 2020 Performance Incentive Plan

    ManagementBoard: FOR

    Approve an amendment to the 2020 Performance Incentive Plan increasing the aggregate number of shares reserved for awards by 1,800,000, from 7,149,047 to 8,949,047 shares.

    More detail

    Proposal 4 asks stockholders to approve an amendment to the 2020 Performance Incentive Plan that would add 1,800,000 shares to the plan’s reserve. The aggregate share limit would rise from 7,149,047 to 8,949,047 shares. Management argues that only 80,032 shares remained available for new grants as of September 8, 2026, leaving insufficient flexibility for future equity compensation. The company uses equity awards to attract, retain, and motivate executives, employees, directors, and certain consultants, with awards including restricted stock units, performance stock units, stock options, stock appreciation rights, and cash awards. Management states that its updated grant practices emphasize senior employees and key engineering talent, reduce reliance on inducement grants, and increase performance-based equity. The company reports that its equity-award burn rate declined from 7.2% in fiscal 2024 to 3.8% in fiscal 2026. If approved, the additional reserve is expected to support grants through approximately the end of fiscal 2029, although that estimate depends on stock price, headcount, forfeitures, performance outcomes, acquisitions, and compensation practices. The requested increase would raise pro forma total equity overhang from approximately 7.03% to 10.87% of shares outstanding. The amendment retains restrictions such as the prohibition on repricing options or stock appreciation rights without stockholder approval. Directors and executive officers are eligible for awards under the plan, giving them an interest in the proposal, but no awards are conditioned on approval of the amendment. The Board unanimously recommends voting FOR, stating that the increase is needed for a competitive performance-oriented program while maintaining disciplined control over dilution.

Director elections

Nominees on the ballot5

Jason Lamb
Independent
Tenure on this board
New nominee
Ownership

Top institutional holders10

Latest 13F quarter
1NEEDHAM INVESTMENT MANAGEMENT LLC5.1%2,400,000$14M
2VANGUARD CAPITAL MANAGEMENT LLC3.3%1,550,312$9M
3BlackRock, Inc.3.0%1,390,997$8M
4STATE STREET CORP3.0%1,380,831$8M
5AWM Investment Company, Inc.Activist2.7%1,250,000$7M
6ROYCE & ASSOCIATES LP2.6%1,216,086$7M
7HEARTLAND ADVISORS INC1.9%900,000$5M
8TWO SIGMA INVESTMENTS, LP1.8%838,158$5M
9CITADEL ADVISORS LLC1.7%786,904$5M
10GEODE CAPITAL MANAGEMENT, LLC1.6%769,208$5M
Filings

Lantronix Inc proxy statements and SEC reports

Annual & quarterly reports (10-K, 10-Q)
Proxy statements (DEF 14A)
Reference

Frequently asked questions

When is the Lantronix Inc 2026 annual meeting?
Lantronix Inc (LTRX) holds its 2026 annual shareholder meeting on Tuesday, November 3, 2026.
What is the record date for the Lantronix Inc 2026 meeting?
The record date for the Lantronix Inc 2026 meeting is Tuesday, September 8, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Lantronix Inc's 2026 meeting?
The board is presenting 5 director nominees at the Lantronix Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Lantronix Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Lantronix Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer